HAKIM NASRAT A (CEO & President) received a stock award from ELITE PHARMACEUTICALS INC /NV/
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/2/2024ACC: 0001493152-24-012832
DirectorOfficer10% Owner· CEO & President
Since Aug 2020
+49.53M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
49.53M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+49.53M
Price / share
—
Trade value
—
% of position
29.6%
3/29/2024
167.11M→216.65M
Total
Net shares
+49.53M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/29/2024 | A · Award | +49.53M | — | — | 29.6% | 167.11M | 216.65M |
| Total | +49.53M | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned2.70M
Common Stock
IndirectShares owned2.22M
Total
4.92M indirect4.92M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.70M | Indirect |
| Common Stock | 2.22M | Indirect |
| Total | 4.92M | 4.92M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported